Astrazeneca Pharmaceuticals Lp v. Food and Drug Administration

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

• noting that the FDCA provides for exclusivity in various “circumstances,” and describing exclu- sivity for new indications or uses as merely “one such circumstance”
• finding comparison between the FDA’s challenged agency action and its past practices probative in determining whether FDA statutory interpretation was reasonable
• testing the FDA's statutory interpretation against Hatch-Waxman's \careful balance\ to ascertain its reasonableness (citations omitted)
• testing the FDA’s statutory interpretation against Hatch-Waxman’s “careful balance” to ascertain its reasonableness (citations omitted)

Source: CourtListener parenthetical corpus (CC0).